Anya Polytech & Fertilizers IPO: Price Band, GMP and other key details you need know before subscribing the upcoming SME issue

Anya Polytech & Fertilizers, is all set to open its public issue for subscription on Thursday, December 26, and will close its bidding window on Monday, December 30. This fresh issue, is offering equity shares priced between Rs 13 and Rs 14 each, with a lot size starting at 10,000 shares.

Here’s everything investors should know before they decide to subscribe.

Anya Polytech IPO – Key Details

The Anya Polytech & Fertilizers IPO is a fresh issue of 3.2 crore equity shares worth Rs 44.80 crore. The price band for this SME issue has been set between Rs 13 to Rs 14 per share. In addition, it is important to note that this is not an Offer for Sale (OFS).

This means the company will be issuing new shares to raise funds, with no existing shareholders selling their stakes.

Also Read International Gemological Institute IPO opens on December 13: Here’s what we know so far Inventurus Knowledge Solutions IPO: This Rekha-Jhunjhunwala backed IPO opens tomorrow- Price band, GMP, and other key details MobiKwik Systems IPO opens tomorrow: IPO allotment status, GMP, and 5 key risk factors you need to know Dhanlaxmi Crop Science IPO: Details of NSE SME IPO allotment status, GMP, listing date, 7 other key details

Investors can bid for a minimum of 10,000 shares, which equates to an investment of Rs 1,40,000. High-net-worth individuals (HNIs) are required to bid for 20,000 shares (Rs 2,80,000).

Also Read: Mamata Machinery IPO allotment today: How to check the allotment status online on NSE, BSE, Link Intime

Anya Polytech IPO – GMP

Currently, Anya Polytech IPO is trading at a premium of Rs 3 in the grey market, indicating an estimated listing of Rs 17, a 21.43 per cent increase from the issue price.

In the DRHP, the company in the risk disclosure write, “We do not own our Registered Office and Corporate Office. A failure to renew our existing lease arrangements at commercially favourable terms or at all may have a material adverse effect on our business, financial condition, and results of operations”

“As of the date of this Draft Red Herring Prospectus, there are outstanding legal proceedings involving our Company, our Subsidiaries and our Promoters and Directors. Any adverse outcome in such legal proceedings may affect our reputation,

 » Read More

Related Articles

Q3FY25 Results: Thyrocare reports 30 percent rise in profit; Revenue stood at Rs 165.9 Crore

Thyrocare on Thursday announced its financial results for the quarter and nine months ended December 31, 2024. According to the company’s statement, the diagnostics major reported revenue of Rs. 165.9 Cr in Q3FY25 with a growth of 23 percent YoY. According to the company’s statement, Thyrocare’s consolidated revenue increased by 23% year-over-year (YoY) with Pathology

Gold prices soar to new peak of Rs 82,900 per 10 gm; silver drops by Rs 500

Gold prices rose Rs 170 to hit a fresh record high of Rs 82,900 per 10 grams in the national capital on Thursday amid a positive global trend, according to the All India Sarafa Association. The precious metal had closed at Rs 82,730 per 10 grams on Wednesday. In about one year, the precious metal

Good news for taxpayers! Govt removes THESE difficulties to ensure more tax cases are settled – Check details!

Good news for taxpayers! The Finance Ministry has made some changes to the Direct Tax Vivad Se Vishwas Scheme, 2024, removing “difficulties” that arose due to certain situations for taxpayers. This update in the scheme will bring relief to taxpayers who wanted to apply for the scheme but could not do so earlier. “CBDT…makes the

LEAVE A REPLY

Please enter your comment!
Please enter your name here

Stay Connected

0FansLike
0FollowersFollow
0SubscribersSubscribe
- Advertisement -

Latest Articles

Q3FY25 Results: Thyrocare reports 30 percent rise in profit; Revenue stood at Rs 165.9 Crore

Thyrocare on Thursday announced its financial results for the quarter and nine months ended December 31, 2024. According to the company’s statement, the diagnostics major reported revenue of Rs. 165.9 Cr in Q3FY25 with a growth of 23 percent YoY. According to the company’s statement, Thyrocare’s consolidated revenue increased by 23% year-over-year (YoY) with Pathology

Gold prices soar to new peak of Rs 82,900 per 10 gm; silver drops by Rs 500

Gold prices rose Rs 170 to hit a fresh record high of Rs 82,900 per 10 grams in the national capital on Thursday amid a positive global trend, according to the All India Sarafa Association. The precious metal had closed at Rs 82,730 per 10 grams on Wednesday. In about one year, the precious metal

Good news for taxpayers! Govt removes THESE difficulties to ensure more tax cases are settled – Check details!

Good news for taxpayers! The Finance Ministry has made some changes to the Direct Tax Vivad Se Vishwas Scheme, 2024, removing “difficulties” that arose due to certain situations for taxpayers. This update in the scheme will bring relief to taxpayers who wanted to apply for the scheme but could not do so earlier. “CBDT…makes the

Johnnie Walker-maker United Spirits posts Q3 profit decline of 4.29% to Rs 335 crore, revenue up 11.06% YoY

United Spirits, which makes Smirnoff vodka, on Thursday reported a profit of Rs 335 crore for the third quarter of FY25, posting a decline of 4.29 per cent in comparison to Rs 350 crore during the corresponding quarter of previous financial year. It posted revenue from operations at Rs 7,732 crore, reporting a growth of

Q3FY25: Mankind Pharma’s revenue up by 24 percent to Rs 3,230 Crore; Profit at Rs 380 crore

Pharma major Mankind Pharma on Thursday reported its financial results for the third quarter and nine months ended 31 st December 2024. The company reported revenue from Operations at Rs. 3,230 Cr, up by 24% YoY and domestic revenue at INR 2,773 Cr, up 17%, Exports at INR 457 Cr, up 121% YoY. The company’s